首页> 外国专利> Peptide nucleic acid probe for multiplex detection of BCR/ABL negative myeloproliferative neoplasm-associated gene mutations

Peptide nucleic acid probe for multiplex detection of BCR/ABL negative myeloproliferative neoplasm-associated gene mutations

机译:肽核酸探针用于多重检测BCR / ABL负髓鞘植物肿瘤相关基因突变

摘要

The present invention provides a peptide nucleic acid probe including any one or more selected from the group consisting of nucleic acid sequences represented by SEQ ID NOs: 7-10 and nucleic acid sequences complementary to the nucleic acid sequences, and manufactured so as to complementarily bind to a BCR/ABL negative myeloproliferative neoplasm-associated gene, thereby enabling multiplex detection of gene mutations; a composition for multiplex detection of gene mutations comprising the same; a kit; and a method for multiplex detection of BCR/ABL negative myeloproliferative neoplasm-associated gene mutations using the same. Therefore, since multiplex detection of BCR/ABL negative myeloproliferative neoplasm-associated gene mutations can be rapidly and accurately carried out by one detection process, BCR/ABL negative myeloproliferative neoplasm is effectively diagnosed, and thus the present invention can be useful for diagnosis, follow-up, prognosis estimation, and treatment of diseases.
机译:本发明提供一种肽核酸探针,包括选自由SEQ ID NO:7-10和与核酸序列互补的核酸序列组成的核酸序列中的任何一种或多种,​​并制造以互补地结合对于BCR / ABL阴性髓系瘤相关基因,从而能够多重检测基因突变;用于多重检测基因突变的组合物;套件;和使用该方法的BCR / ABL阴性髓样肿瘤相关基因突变的多重检测方法。因此,由于通过一个检测过程可以快速且准确地进行BCR / Abl阴性髓样肿瘤相关基因突变的多重检测,因此有效地诊断了BCR / Abl阴性髓样肿瘤,因此本发明可用于诊断,遵循-Up,预后估计和疾病治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号